» Journals » J Neurodev Disord

Journal of Neurodevelopmental Disorders

The Journal of Neurodevelopmental Disorders is a peer-reviewed publication dedicated to advancing the understanding and treatment of neurodevelopmental disorders. It features high-quality research articles, reviews, and case studies that explore the genetic, environmental, and neurological factors contributing to these disorders. The journal serves as a valuable resource for researchers, clinicians, and educators seeking to improve the lives of individuals affected by neurodevelopmental disorders.

Details
Abbr. J Neurodev Disord
Publisher Biomed Central
Start 2009
End Continuing
Frequency Quarterly
p-ISSN 1866-1947
e-ISSN 1866-1955
Country United Kingdom
Language English
Specialties Neurology
Psychiatry
Metrics
h-index / Ranks: 6023 61
SJR / Ranks: 2140 1422
CiteScore / Ranks: 3528 6.30
JIF / Ranks: 1632 4.9
Recent Articles
1.
Begum-Ali J, Mason L, Charman T, Johnson M, Green J, Garg S, et al.
J Neurodev Disord . 2025 Mar; 17(1):12. PMID: 40087579
Background: Neurofibromatosis Type 1 is a genetic condition diagnosed in infancy that substantially increases the likelihood of a child experiencing cognitive and developmental difficulties, including Autism Spectrum Disorder (ASD) and...
2.
Hong X, Farmer C, Kozhemiako N, Holmes G, Thompson L, Manwaring S, et al.
J Neurodev Disord . 2025 Feb; 17(1):11. PMID: 39987026
Background: Changes in brain connectivity during development are thought to reflect organizational and maturational processes that correspond to skill acquisition in domains like motor, language, and cognition. This theory is...
3.
LaSalle J
J Neurodev Disord . 2025 Feb; 17(1):10. PMID: 39972408
Epigenetic mechanisms, including DNA methylation, act at the interface of genes and environment by allowing a static genome to respond and adapt to a dynamic environment during the lifespan of...
4.
Wang X, Bouton S, Kojovic N, Giraud A, Schaer M
J Neurodev Disord . 2025 Feb; 17(1):9. PMID: 39966708
Background: Children with Autism Spectrum disorder (ASD) often exhibit communication difficulties that may stem from basic auditory temporal integration impairment but also be aggravated by an audio-visual integration deficit, resulting...
5.
Waugh J, Hassan A, Funk A, Maldjian J
J Neurodev Disord . 2025 Feb; 17(1):8. PMID: 39955485
Background: Autism spectrum disorder (ASD) is the second-most common neurodevelopmental disorder in childhood. This complex developmental disorder manifests with restricted interests, repetitive behaviors, and difficulties in communication and social awareness....
6.
Cromb D, Finck T, Bonthrone A, Uus A, Van Poppel M, Steinweg J, et al.
J Neurodev Disord . 2025 Feb; 17(1):7. PMID: 39939911
Background: Improved long-term outcomes, related to advances in surgical and clinical care of infants with congenital heart disease (CHD), has shifted focus onto the accompanying and later-onset cognitive and neuropsychiatric...
7.
Dykens E, Roof E, Hunt-Hawkins H, Strong T
J Neurodev Disord . 2025 Feb; 17(1):6. PMID: 39923017
Background: Prader-Willi syndrome (PWS), a genetic neurodevelopmental disorder, is characterized by hyperphagia and significant behavioral problems. Hyperphagic individuals with PWS are chronically hungry yet rarely feel sated, and often engage...
8.
Gimbel B, Wozniak J, Mueller B, Tuominen K, Ernst A, Anthony M, et al.
J Neurodev Disord . 2025 Feb; 17(1):5. PMID: 39910445
Background: Prenatal alcohol exposure (PAE) impacts hippocampal structure and function, contributing to deficits in memory and decision-making in affected individuals. Here, we evaluate hippocampal anomalies in children with PAE and...
9.
Nie H, Lan S, Wang H, Xiang P, Yan M, Fan Y, et al.
J Neurodev Disord . 2025 Jan; 17(1):3. PMID: 39856544
Background: Spinal muscular atrophy (SMA) is caused by reduced expression of survival motor neuron (SMN) protein. Previous studies indicated SMA causes not only lower motor neuron degeneration but also extensive...
10.
Campbell K, Neul J, Lieberman D, Berry-Kravis E, Benke T, Fu C, et al.
J Neurodev Disord . 2025 Jan; 17(1):4. PMID: 39856538
Background: Preclinical studies and anecdotal case reports support the potential therapeutic benefit of low-dose oral ketamine as a treatment of clinical symptoms in Rett syndrome (RTT); however, no controlled studies...